Pharmaceutical Excipients Market worth US$ 10.49 billion by 2030 with a CAGR of 5.3%.

 



Pharmaceutical excipients are substances other than an active pharmaceutical ingredient contained in a drug delivery system. Pharmaceutical excipients are inactive substances contributing to lubricity, fluidity, disintegration, taste and can impart some form of antimicrobial function. Pharmaceutical excipients are used to simplify the manufacture of pharmaceutical products and help to promote the physiological absorption of the drug. These are also used to protect, support, or enhance stability of the formulation. Pharmaceutical excipients are substances other than the active pharmaceutical ingredient (API) that have been appropriately evaluated for safety and are intentionally included in a drug delivery system. Simply said the excipients enable the drug substance to be applied to the patient in the right form and supports the way and place of action without being active themselves. The Global Pharmaceutical Excipients Market accounted for US$ 6.52 billion 2020 and is estimated to be US$ 10.49 billion by 2030 and is anticipated to register a CAGR of 5.3%.

 

The report "Global Pharmaceutical Excipients Market, by Product (Organic Chemicals and Inorganic Chemicals), by Functionality (Fillers and Diluents, Binders, Disintegrants, Lubricants And Glidants, and Others (Coating Agents, Preservatives, Emulsifying Agents, and Flavoring Agents And Sweeteners)), by Formulation (Oral Formulations, Topical Formulations, Parenteral Formulations, and Others (Vaginal Inhaled, Ophthalmic, and Optic)), and Region - Global Forecast to 2029" The Global Pharmaceutical Excipients Market accounted for US$ 6.52 billion 2020 and is estimated to be US$ 10.49 billion by 2030 and is anticipated to register a CAGR of 5.3%. This is attributed to excipients have been provide better functionality and competitive advantage in drug formulations in turns increases demand from pharmaceutical industry. Furthermore, rising demand for generic medicine across the globe the global pharmaceutical excipients market.

Key Highlights:

·         On December 2016, Merck & Co., Inc launched “Parteck MXP” which is a polyvinyl alcohol-based excipient that enhances solubility of a wide range of active.

·         On February 5, 2019, ABITEC Corporation launched “CAPMUL GDB EP/NF”. This is high-purity, highly-reproducible solid lipid exipient which offers good flow and uniform particle size distribution for use in multiple fomrulations, including tablets, hard gels, softgels, solid lipid nanoparticles, nano-structured lipids, granulations, multi-particulates, extrudates, congealing, and liquids.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

 

Key Market Insights from the report:          

The global pharmaceutical excipients market accounted for US$ 10.49 billion by 2030 and is projected to register a moderate CAGR of 5.3%. over the forecast period. The market report has been segmented on the basis of product, functionality, formulation, and region.

·         By product, the organic chemical is segment accounted for major revenue share in 2018, owing to it this organic chemicals increases efficiency regarding poorly soluble orally delivered molecules.

·         By functionality, fillers and diluents is segment accounted for major revenue share in 2018, due to increasing use of fillers and diluents in the development and production of solid oral drugs.

·         By formulation, parenteral formulations is segment accounted for major revenue share in 2018, attributed to parenteral formulations is major line treatment for infectious diseases, hepatitis, tuberculosis, cardiovascular diseases, diabetes, and cancer. 

·         By region, The Europe pharmaceutical excipients market is expected to dominate in the global pharmaceutical excipients market and is further anticipated to maintain its dominance over the forecast period, owing to presence of European Medicines Agency’s scientific guidelines on excipients, which facilitates pharmaceutical entities to prepare marketing authorization applications for medicines for human consumption in the European countries. The North America pharmaceutical excipients market is expected to account for second-highest share in terms of revenue in the near future, followed by Asia Pacific in 2018.

 

The prominent player operating in the global pharmaceutical excipients market includes Eastman Chemical Company, The Procter & Gamble Manufacturing Company, Merck & Co., Inc., Avantor Performance Materials, LLC, Huntsman Corporation, ABITEC Corporation, BASF SE, Ashland Global Holdings Inc, FMC Corporation, Colorcon, Inc, and Roquette Frères S.A.

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Antibody Drug Conjugate Market is estimated to be US$ 27.0 billion by 2030 with a CAGR of 23.5% during the forecast period

Image
  Antibody drug conjugate market accounted for US$ 3.3 billion in 2020 and is estimated to be US$ 27.0 billion by 2030 and is anticipated to register a CAGR of 23.5% . Antibody-drug conjugates or ADCs are biopharmaceutical drugs designed for targeted therapy for treating various type of cancer. ADCs are expose to target and kill tumor cells while sparing healthy cells. As of now 59npharmaceutical companies developed ADCs. These are complex molecules composed of antibody and have capability to target cancer cells by discriminating healthy tissues and diseased tissues. The report "   Global Antibody Drug Conjugate Market, By Technology (Cleavable Linker and Non-Cleavable Linker), By Application (Blood Cancer, Ovarian Cancer, Lung Cancer and Brain Tumor), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”...
Read more

Inulin Market is estimated to be US$ 2.29 billion by 2030 with a CAGR of 5.5% during the forecast period

Image
  The report "Global Inulin Market , By Application (Food and Beverage, Dietary Supplements, and Pharmaceutical) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”. Increasing awareness about prebiotic ingredients and their extensive utilization in food and beverages industry is the major factor driving the growth of the global inulin market globally. Inulin has various applications in dairy product formation such as cheese, yogurts, and ice-cream. Hence, the growth in dairy industries is projected to boost additional growth in inulin market over the forecast period. Also, high growth in the pharmaceuticals industry worldwide is propelling the growth of the target market. Furthermore, the fast-growing significance of nutraceuticals due to increasing health awareness is expected to increase demand for inulin as a functional ingredient. Key Highlights: In June 2018, Cosucra’s inulin-type fru...
Read more

Intraocular Lens Market is estimated to be US$ 7.9 billion by 2032 with a CAGR of 7.2% over the forecast period (2022-2032)

Image
  The Intraocular Lenses implant is routinely utilized during cataract surgery. Intraocular Lenses work as natural lenses. Lens implant has various focusing powers like prescription contact lenses or eyeglasses. There are different types of Intraocular Lenses like – Monofocal IOLs, which has one focal point & can be set to focus on close, medium, and distance vision which is based on preference. Distance vision is the most common selection. Trifocal IOLs, help to see better in distance, computer distance, and reading distance. Trifocal IOLs help in allowing to see both the distance and near while looking in any kind of direction. Toric IOLs is used if one has significant eye astigmatism. Astigmatism result when cornea flatter in one direction like a football. Toric Intraocular Lenses are designed for correcting astigmatism and allows to have great vision without glasses. Phakic lenses are commonly used for correcting moderate to severe nearsightedness. Phakic lenses are surgic...
Read more